ClinicalTrials.gg
RecruitingNCT07716475Updated Jul 21, 2026

Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients

An interventional study of hip-assisted wearable robot in Stroke, sponsored by Yonsei University. Recruiting at 1 site in South Korea. Open to participants aged 19 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Yonsei University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
19 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Stroke by Yonsei University — 9 open to participants now, 11 under way, none of them phase 3. Stroke · Yonsei University.

Planned enrollment
22nd of 22
8 · median 46
Started
2026
with 2 others
No phase
16 of 28
3 open now
Primary completion
2026-09
later than 6 of 10 live
Registered
27th of 28
by date

Among the 28 studies in Stroke by Yonsei University, this one is the 22nd largest by planned enrollment of the 22 interventional ones that give a count, is one of 3 that started in 2026, is one of 16 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 27th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

9 of the 28 studies in Stroke by Yonsei University are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 19 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Stroke by Yonsei University, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether a wearable monitoring system can help adults who have had a stroke get more out of a home exercise program. The system tracks how participants walk and move, then gives them feedback. Researchers want to know if this feedback improves walking, thinking and memory, and daily activity.

The wearable monitoring system has three parts:

A shoe insole sensor that measures how a person walks A wrist band that tracks daily activity, like a fitness watch A mobile app that gives feedback and lets participants report how they feel

The main questions this study aims to answer are:

Does feedback from the wearable system improve physical function, thinking and memory, and daily activity during a home exercise program? How satisfied are participants with using the wearable system?

Researchers will compare two groups. Both groups do the same home exercise program for 6 weeks. One group uses the wearable system and gets feedback. The other group does the program without the wearable system or feedback. This comparison shows whether the feedback itself makes a difference.

Who can take part: adults who have had a stroke and [key eligibility in plain words, e.g., "can walk a short distance with or without help"]. The study plans to enroll about [number] participants.

Participants in the wearable group will:

Get an insole sensor, a wrist activity tracker, and access to a mobile app Learn a home exercise program from the study team Wear the insole sensor and activity tracker while exercising at home for 6 weeks Use the app to see their feedback and report daily health information Complete a survey about their experience at the end

Participants in the comparison group will:

Do the same home exercise program for 6 weeks, without the wearable system or feedback.

Read the detailed description

After obtaining written consent, a screening test is performed. In the screening test, after taking a history of the subject's baseline symptoms and signs, the past history and medication history are confirmed, vital signs are measured, and a physical examination is conducted, and the overall gait status such as whether assistive devices are used during gait and the gait pattern is assessed. Subjects who pass the screening test undergo the initial assessment within 7 days.

The initial assessment is conducted including the 2-Minute Walk Test, spatiotemporal gait parameters, the Berg Balance Scale, and subjects who complete the initial assessment begin robot-assisted gait training on the same day.

After the initial assessment, gait training using the hip-assisted wearable robot is performed in the home or an indoor space near the home twice a week for 2 weeks, a total of 4 times, for 30 minutes each. The interval between each intervention visit is set not to exceed 5 days.

After the end of the 2 weeks of robot-assisted gait training, on the day of completion, the end-of-study assessment is performed identically to the initial assessment, and a satisfaction assessment for the hip-assisted wearable robot is conducted.

In addition, when a device abnormality occurs, measures are taken and the relevant details are recorded, the usability of the hip-assisted wearable robot is analyzed, the gait and balance function assessment results in the non-wearing/wearing states of the hip-assisted wearable robot are statistically compared before and after gait training, and the burden and satisfaction assessments of the hip-assisted wearable robot are analyzed.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Home-based rehabilitation
  • Robot-assisted gait training
  • Telehealth
  • Exoskeleton Device
  • Stroke
04

Who can participate

Ages eligible
19 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults aged 19 years or older and under 80 years
  2. Persons diagnosed with cerebral infarction or intracerebral hemorrhage confirmed by magnetic resonance imaging or computed tomography
  3. Persons for whom at least 1 month has elapsed since the diagnosis of stroke
  4. Persons showing a spastic hemiplegic gait pattern due to stroke
  5. Patients with a Functional Ambulatory Category score below 4
  6. Persons who can sit without assistance at the edge of a bed and can stand for 10 seconds with or without assistance
  7. Persons with sufficient cognitive ability to follow simple instructions and understand the content and purpose of the study ( score >= 20)

Exclusion criteria

Exclusion Criteria:

  1. Persons with to lower-extremity weight bearing, such as severe lower-extremity joint contracture or an untreated fracture
  2. Persons for whom wearing the device is difficult due to skin disease or open wounds
  3. Persons with a severe difference in the length of the two lower extremities
  4. Persons with severe deformity or joint contracture in the lower extremities
  5. Persons unable to maintain a sitting posture or a standing posture on their own
  6. Persons with severe lower-extremity spasticity (Modified Ashworth Scale (MAS) grade 2 or higher)
  7. Persons who cannot cooperate with gait therapy using the robot-assisted orthopedic exercise device due to severe cognitive decline ( score \< 20), delirium, or severe language function impairment
  8. Persons who cannot maintain prolonged standing or walking due to underlying conditions such as orthostatic hypotension or reduced cardiopulmonary function
  9. Persons with other concomitant conditions affecting gait, such as peripheral neuropathy or parkinsonism due to alcoholism or severe diabetes
  10. Pregnant women or patients with the possibility of pregnancy
  11. Persons currently participating in another clinical trial
  12. Persons at high risk in the event of a fall or bleeding due to a coagulation disorder or the like
  13. Persons with a height less than 140 cm or greater than 190 cm
  14. Persons for whom wearing the robot is not possible
  15. Persons with findings that, in the medical judgment of the principal investigator or a sub-investigator, are considered inappropriate for this study other than the above
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (estimated)

Study arms

  • Experimental
    Intervention group (Home-based Robot-assisted Gait training group)

    Participants receive home-based robot-assisted gait training using a hip-assisted wearable robot. A visiting physical or occupational therapist delivers the training at the participant's home for 4 sessions over 2 weeks, 30 minutes per session, under a physician's prescription and supervision.

    Device: hip-assisted wearable robot

Interventions

  • Devicehip-assisted wearable robot

    A hip-assisted wearable robot (wearable gait-assist robot) that assists flexion and extension of the hip joint during walking. The battery-powered device is controlled through a paired mobile application via Bluetooth, and its assistive force can be adjusted to each participant. A visiting physical or occupational therapist applies the device and delivers gait training at the participant's home for 4 sessions over 2 weeks, 30 minutes per session, under a physician's prescription and supervision.

06

What researchers measure

Primary outcomes

  1. Telehealth Usability Questionnaire (TUQ)

    Usability of the home-based robot-assisted gait rehabilitation service, measured with a questionnaire based on the Telehealth Usability Questionnaire (TUQ). Items are rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree); higher scores indicate better usability. Total and item scores are summarized.

    Time frame: At the end of the 2-week intervention (after session 4)

Secondary outcomes

  1. Distance of 2-Minute Walk Test (2MWT)

    Patients are instructed to walk back as many times as possible within 2 minutes. The examiner records the total distance covered, abnormal gait patterns, and the time of occurrence of any gait deviations.

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  2. Spatiotemporal Parameters of Gait: Cadence

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Cadence: The number of steps taken per minute, measured in steps per minute (spm).

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  3. Spatiotemporal Parameters of Gait : Total Step Count

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Total Step Count: The total number of steps taken during walking.

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  4. Spatiotemporal Parameters of Gait : Self-Selected Walking Speed

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Self-Selected Walking Speed: The participant's walking speed when walking naturally at a comfortable pace.

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  5. Spatiotemporal Parameters of Gait : Distance

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Distance: The total distance covered during walking, measured in meters (m).

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  6. Spatiotemporal Parameters of Gait : Stride Length

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Stride Length: The distance between the heel of one foot to the heel of the same foot during consecutive steps. Measured in meters (m), stride length is adjusted for height to account for differences in body size.

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  7. Berg Balance Scale (BBS)

    Patients are asked to perform 14 tasks regarding the static and dynamic balance of patients. Each task was rated on a five-point scale from 0 to 4, with a total score of 56.

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

  8. Participant Satisfaction (K-QUEST 2.0-based)

    Satisfaction with the device and home-based service, measured with the 12-item, 5-point Korean version of the Quebec User Evaluation of Satisfaction with Assistive Technology (K-QUEST 2.0). Each item is scored from 1 to 5, and the total score is the sum of the 12 items, ranging from a minimum of 12 to a maximum of 60. Higher scores indicate greater satisfaction.

    Time frame: At the end of the 2-week intervention (after session 4)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Lee S-H, Jung B-K, Park S-Y. Korean translation and psychometric properties of Quebec user evaluation of satisfaction assistive technology 2.0. Journal of the Korea Academia-Industrial Cooperation Society 2013;14:3284-3292
  • Lee MH, Tian MY, Kim MK. The Effectiveness of Overground Robot Exoskeleton Gait Training on Gait Outcomes, Balance, and Motor Function in Patients with Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Brain Sci. 2024 Aug 19;14(8):834. doi: 10.3390/brainsci14080834. PubMed 39199525 ↗
  • Bang DH, Shin WS. Effects of robot-assisted gait training on spatiotemporal gait parameters and balance in patients with chronic stroke: A randomized controlled pilot trial. NeuroRehabilitation. 2016 Apr 6;38(4):343-9. doi: 10.3233/NRE-161325. PubMed 27061162 ↗
  • Godi M, Franchignoni F, Caligari M, Giordano A, Turcato AM, Nardone A. Comparison of reliability, validity, and responsiveness of the mini-BESTest and Berg Balance Scale in patients with balance disorders. Phys Ther. 2013 Feb;93(2):158-67. doi: 10.2522/ptj.20120171. Epub 2012 Sep 27. PubMed 23023812 ↗
  • Kosak M, Smith T. Comparison of the 2-, 6-, and 12-minute walk tests in patients with stroke. J Rehabil Res Dev. 2005 Jan-Feb;42(1):103-7. doi: 10.1682/jrrd.2003.11.0171. PubMed 15742254 ↗
  • Parmanto B, Lewis AN Jr, Graham KM, Bertolet MH. Development of the Telehealth Usability Questionnaire (TUQ). Int J Telerehabil. 2016 Jul 1;8(1):3-10. doi: 10.5195/ijt.2016.6196. eCollection 2016 Spring. PubMed 27563386 ↗
  • Zimmermann J, Morf H, Scharf F, Knitza J, Moeller H, Muehlensiepen F, Nathrath M, Orlemann T, Voelker T, Deckers M. German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation Study. JMIR Hum Factors. 2024 Nov 21;11:e57771. doi: 10.2196/57771. PubMed 39571151 ↗
  • Kang YW, Na DL, Hahn SH. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15(2):300-308.5
  • Mehrholz J, Wagner K, Rutte K, Meissner D, Pohl M. Predictive validity and responsiveness of the functional ambulation category in hemiparetic patients after stroke. Arch Phys Med Rehabil. 2007 Oct;88(10):1314-9. doi: 10.1016/j.apmr.2007.06.764. PubMed 17908575 ↗
  • Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil. 1999 Sep;80(9):1013-6. doi: 10.1016/s0003-9993(99)90053-9. PubMed 10489001 ↗
  • Gajdosik RL, Bohannon RW. Clinical measurement of range of motion. Review of goniometry emphasizing reliability and validity. Phys Ther. 1987 Dec;67(12):1867-72. doi: 10.1093/ptj/67.12.1867. PubMed 3685114 ↗
  • Chin LF, Lim WS, Kong KH. Evaluation of robotic-assisted locomotor training outcomes at a rehabilitation centre in Singapore. Singapore Med J. 2010 Sep;51(9):709-15. PubMed 20938611 ↗
  • De Luca R, Maresca G, Balletta T, Cannavo A, Leonardi S, Latella D, Maggio MG, Portaro S, Naro A, Calabro RS. Does overground robotic gait training improve non-motor outcomes in patients with chronic stroke? Findings from a pilot study. J Clin Neurosci. 2020 Nov;81:240-245. doi: 10.1016/j.jocn.2020.09.070. Epub 2020 Oct 15. PubMed 33222923 ↗
  • Chou CH, Hwang CL, Wu YT. Effect of exercise on physical function, daily living activities, and quality of life in the frail older adults: a meta-analysis. Arch Phys Med Rehabil. 2012 Feb;93(2):237-44. doi: 10.1016/j.apmr.2011.08.042. PubMed 22289232 ↗
  • Lange AK, Vanwanseele B, Fiatarone Singh MA. Strength training for treatment of osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2008 Oct 15;59(10):1488-94. doi: 10.1002/art.24118. PubMed 18821647 ↗
  • Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996 Jan 11;334(2):71-6. doi: 10.1056/NEJM199601113340202. PubMed 8531961 ↗
  • Salzman B. Gait and balance disorders in older adults. Am Fam Physician. 2010 Jul 1;82(1):61-8. PubMed 20590073 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Sep 2026, 2 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 2 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Jul 21, 2026
StartActual
Jul 6, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Jul 30, 2027
Last update
Jul 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07716475
Lead sponsor
Yonsei University
Collaborators
Korea Health Industry Development Institute
Responsible party
Na Young Kim (Assistant Professor, Severance Hospital) — Principal investigator
First posted
Jul 21, 2026
Start date
Jul 6, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Jul 21, 2026

Study contacts

Na Young Kim, MD, PhD
Contact
kny8452@yuhs.ac
+82 010 9127 4482
Seung Ick Choi
Contact
rehab1@yuhs.ac
+82 010 8821 5297
Na Young Kim, MD, PhD
principal investigator · Severance Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion